Hints and tips:
Showing results for Astra Zeneca Pharmaceutical Company
...Scientific collaboration between Sweden and the UK is already close, anchored in pharmaceuticals by AstraZeneca, the drug company created by the 1999 merger of Britain’s Zeneca with Sweden’s Astra....
...Part of ICI lives on, being the UK pharmaceutical firm Zeneca which was demerged from ICI in 1993 with Astra (Swedish) Zeneca coming together in 1999....
...Most recently, Chris Sheldon joined from AstraZeneca, after the companies settled a lawsuit that claimed that his move broke a non-compete clause in his Astra contract....
...Another said: “Astra is not going to get approved here — we don’t need it.”...
...The Covid Recovery Commission, comprised of executives from companies including Vodafone, Astra Zeneca and Shell, said the pandemic had exacerbated existing inequalities and had a bigger impact on the UK...
...It’s easy to forget how tarnished the current golden child of UK pharmaceuticals was back then....
...“I think these things take time and then I can remember meeting investors with Astra and being challenged about progress in oncology,” he said....
...Astra: Bryce.elder@ft.com Auto Trader: Kate.burgess@ft.com...
...José Baselga, Astra’s oncology research and development chief, said the deal was “right there” with the company’s strategy....
...“Astra were rock solid because our contract is rock solid,” said one ally of Hancock. “It’s quite simple: we have an exclusivity contract with them and the EU don’t.”...
...Investors will also have an eye on energy major ExxonMobil and pharmaceutical group Pfizer....
...The company could still benefit from others’ initiatives, too. Its stake in Moderna, developer of a novel vaccine technology, is worth more than four times Astra’s investment....
...Quarterly revenues rose 16 per cent year-on-year while “core” earnings per share climbed 17 per cent, the company said on Wednesday. Astra does have runners in the coronavirus race, too....
...On the call with investors on Wednesday, Mr Raffat said: “If I want to take a vaccine in January, I’ll probably want to take Astra for a T-cell response and Moderna or Pfizer BioNTech for a neutralising...
...Sales of the company’s new medicines rose 62 per cent to just under $10bn, representing 42 per cent of total product revenues compared with 30 per cent in 2018....
...When in 2017 a new drug combination for lung cancer, in which the company had invested enormous hopes, failed in a clinical trial, wiping £10bn off Astra’s value, the group’s fortunes seemed to have reached...
...After the disappointing results, the pharmaceutical group said it would discontinue trials on the drug, known as Epanova, and carry out a review into its $533m value on the company’s balance sheet....
...He joined Merck in 1992 as general counsel of a joint venture between the US drugmaker and Astra, the Swedish half of today’s AstraZeneca....
...It was originally occupied by ICI, one of the giants of the UK’s postwar industrial landscape, whose bioscience business Zeneca demerged in 1993, joining forces with Sweden’s Astra six years later....
...Zeneca eventually combined with Astra of Sweden to form the modern-day AstraZeneca....
...The last couple of years have seen the first breakthroughs in pharmaceuticals for depression in decades: Johnson & Johnson's ketamine-derived nasal spray Spravato and Sage Therapeutics first post-partum...
...Adam Barker, analyst at Shore Capital, said: “We continue to see Astra as a compelling growth story, with the outlook under-pinned by a diversified portfolio of five on-market assets and near-term pipeline...
...The row, first disclosed by The Times, centred on Astra’s decision to sell the manufacturing site in Avonmouth, Bristol — known as Avlon — to the pharma company Avara for £1 at the end of 2016....
...At the European Society for Medical Oncology conference in Barcelona, Astra together with its development partner Merck, announced that adding Lynparza to another drug, Avastin, reduced the risk of disease...
...So-called collaboration revenue, when the company raises money by selling assets or collaborating with other companies to develop drugs and which was a significant element in underpinning Astra’s revenues...
International Edition